6Suppliers
2Customers
3Debt Items
20Related Chains

Cognition Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
JEFFERIES-LLC JEFFERIES-LLC 92% The Company may sell, from time to time, at its option, shares of the Company’s common stock, through or to Jefferies, as sales agent or principal (the “ATM Offering”).
THIRD-PARTY-CONTRACT-MANUFACTURER THIRD-PARTY-CONTRACT-MANUFACTURER 92% Currently, we rely on and have agreements with a single third-party contract manufacturer to supply the zervimesine drug substance and with a single third-party contract manufacturer to manufacture c…
B-RILEY-SECURITIES-INC B-RILEY-SECURITIES-INC 90% On December 16, 2025, the Company delivered written notice to B. Riley Securities, Inc. to terminate the Previous Sales Agreement, effective December 18, 2025.
JEFFERIES JEFFERIES 80% which registered the offering, issuance and sale of up to $ 300.0 million of various equity and debt securities and up to $ 75,000 of common stock pursuant to an at-the-market equity offering program…
ORANY ORANY 72% tured, or disagrees with the promotion, marketing or labeling of a product, such regulatory agency may impose restrictions on that product or us, including requiring withdrawal of the product from th…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from CGTX graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from CGTX graph: tured, or disagrees with the prom…

Cognition Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
ORANY ORANY 72% the Orange Book, those ANDAs and 505(b)(2) NDAs would be required to include a certification as to each listed patent indicating whether the ANDA applicant does or does not intend to challenge the pa…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from CGTX graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from CGTX graph: Reciprocal relationship from ORAN…

Cognition Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CGTX-DEBT Debt stack $638,000 90% Market cache reports total debt of $638,000.
CGTX-DEBT-8615 Warrants outstanding: 34000 90% xbrl warrant detail from xbrl 2021-12-31.
CGTX-DEBT-8616 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.

Cognition Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Cognition Therapeutics, Inc..

Cognition Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
CGTX-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 75 tracked holders.

Cognition Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ORANY ORANGE 100.00 1 ['customer', 'supplier']
AMZE Amaze Holdings, Inc. 50.00 2
DWTX Dogwood Therapeutics, Inc. 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
D Dominion Energy, Inc. 50.00 2
DARE Daré Bioscience, Inc. 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
DFTX Definium Therapeutics, Inc. 50.00 2
CHUC Charlie's Holdings, Inc. 50.00 2
CLNE Clean Energy Fuels Corp. 50.00 2
FENC Fennec Pharmaceuticals Inc. 50.00 2
EQR Equity Residential 50.00 2
CNOB ConnectOne Bancorp, Inc. 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2
ESS Essex Property Trust, Inc. 50.00 2
ED Consolidated Edison, Inc. 50.00 2
SCNX Scienture Holdings, Inc. 50.00 2
CORT Corcept Therapeutics Incorporated 50.00 2
BLTE Belite Bio, Inc 50.00 2